These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 21239876)
21. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells. Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953 [TBL] [Abstract][Full Text] [Related]
22. Cholesteryl esters: fueling the fury of prostate cancer. Peck B; Schulze A Cell Metab; 2014 Mar; 19(3):350-2. PubMed ID: 24606894 [TBL] [Abstract][Full Text] [Related]
23. Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice. Kilic U; Caglayan AB; Beker MC; Gunal MY; Caglayan B; Yalcin E; Kelestemur T; Gundogdu RZ; Yulug B; Yılmaz B; Kerman BE; Kilic E Redox Biol; 2017 Aug; 12():657-665. PubMed ID: 28395173 [TBL] [Abstract][Full Text] [Related]
24. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Liu S; Wang XJ; Liu Y; Cui YF Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146 [TBL] [Abstract][Full Text] [Related]
25. PI(3)king apart PTEN's role in cancer. Zhang S; Yu D Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047 [TBL] [Abstract][Full Text] [Related]
26. How moderate changes in Akt T-loop phosphorylation impact on tumorigenesis and insulin resistance. Wullschleger S; Sakamoto K; Johnstone L; Duce S; Fleming S; Alessi DR Dis Model Mech; 2011 Jan; 4(1):95-103. PubMed ID: 20959631 [TBL] [Abstract][Full Text] [Related]
28. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT. Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285 [TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways. Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444 [TBL] [Abstract][Full Text] [Related]
30. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement. Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877 [TBL] [Abstract][Full Text] [Related]
32. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt. Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057 [TBL] [Abstract][Full Text] [Related]
33. Cancer therapy: staying current with AMPK. Fruman DA; Edinger AL Biochem J; 2008 Jun; 412(2):e3-5. PubMed ID: 18466113 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling. Yang X; Chen G; Chen Z J Cardiovasc Pharmacol; 2019 Nov; 74(5):453-461. PubMed ID: 31651553 [TBL] [Abstract][Full Text] [Related]
35. Modeling human disease in yeast: recreating the PI3K-PTEN-Akt signaling pathway in Saccharomyces cerevisiae. Coronas-Serna JM; Valenti M; Del Val E; Fernández-Acero T; Rodríguez-Escudero I; Mingo J; Luna S; Torices L; Pulido R; Molina M; Cid VJ Int Microbiol; 2020 Jan; 23(1):75-87. PubMed ID: 31218536 [TBL] [Abstract][Full Text] [Related]
36. A crucial role for the phosphorylation of STRAP at Ser(188) by MPK38 in STRAP-dependent cell death through ASK1, TGF-β, p53, and PI3K/PDK1 signaling pathways. Seong HA; Manoharan R; Ha H Cell Cycle; 2014; 13(21):3357-74. PubMed ID: 25485581 [TBL] [Abstract][Full Text] [Related]
37. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Vazquez F; Sellers WR Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987 [No Abstract] [Full Text] [Related]
38. The relation between PI3K/AKT signalling pathway and cancer. Noorolyai S; Shajari N; Baghbani E; Sadreddini S; Baradaran B Gene; 2019 May; 698():120-128. PubMed ID: 30849534 [TBL] [Abstract][Full Text] [Related]
39. Phosphatidylinositol 3-kinase signaling in thymocytes: the need for stringent control. Fayard E; Moncayo G; Hemmings BA; Holländer GA Sci Signal; 2010 Aug; 3(135):re5. PubMed ID: 20716765 [TBL] [Abstract][Full Text] [Related]
40. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas. Nozhat Z; Hedayati M Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]